Study flags dominant E198A mutation in resistant H. contortus

A newly published study in Veterinary Sciences adds another signal that benzimidazole resistance in Haemonchus contortus in China is being shaped by the E198A mutation, not just the better-known F200Y variant. In parasite populations collected from Yili Prefecture in Xinjiang, the authors found E198A was the dominant resistance-associated change and reported signs of emerging co-selection, suggesting more than one resistance-linked genotype may now be moving together under drug pressure. (pmc.ncbi.nlm.nih.gov)

That matters because H. contortus remains one of the most important gastrointestinal nematodes in sheep, and benzimidazole resistance has become a global constraint on parasite control. The molecular basis of benzimidazole resistance in this species is among the best characterized in veterinary parasitology, with three main isotype-1 β-tubulin substitutions commonly tracked: F167Y, E198A, and F200Y. But their prevalence differs by geography, and earlier work has suggested that China stands out for the prominence of E198A. (nature.com)

The new paper also fits a regional pattern building in Xinjiang. A 2024 report from southern Xinjiang described the first molecular detection of benzimidazole resistance in H. contortus from Hejing and Minfeng counties and found E198A at higher frequency than F200Y. A 2025 Veterinary Parasitology study from four southern Xinjiang regions likewise reported no F167Y mutation, but varying frequencies of E198A and F200Y, along with evidence of strong gene flow among populations. Taken together, those findings suggest resistance-associated alleles are not isolated events, and may be spreading through animal movement and repeated benzimidazole exposure. (pubmed.ncbi.nlm.nih.gov)

The co-selection point is especially notable. Earlier genetic work in China found that E198A likely arose from at least two distinct origins before spreading across regions, while newer digital PCR research has suggested treatment can shift allele frequencies in favor of E198A relative to F200Y in some settings. Experimental work has also indicated that E198A can confer substantial benzimidazole resistance, in some cases at a higher level than F200Y. The implication, while still an inference rather than a direct field-efficacy result from this paper, is that selection pressure may be enriching a more complex resistance landscape than a single-SNP model would capture. (pmc.ncbi.nlm.nih.gov)

Independent expert-oriented sources broadly support that interpretation. Reviews of H. contortus resistance describe benzimidazole resistance as a major and growing threat, and the Merck Veterinary Manual notes that cross-resistance within the benzimidazole class is common because these drugs share a mechanism of action. WAAVP guidance continues to treat fecal egg count reduction testing as the field standard for confirming reduced efficacy, while recognizing that mixed-species infections and evolving genotypes can complicate interpretation. (merckvetmanual.com)

Why it matters: For veterinarians, diagnosticians, and flock advisors, this study is a reminder that resistance surveillance needs to be locally informed. In practical terms, if E198A is dominant in a given region and co-selection with other resistance-associated variants is emerging, molecular assays that focus too narrowly on F200Y could underread resistance risk. It also strengthens the case for pairing genotype data with phenotypic tools such as FECRT, and for integrating resistance management strategies such as targeted selective treatment and refugia-based control rather than repeated class-wide benzimidazole use alone. (sciencedirect.com)

This is livestock parasitology rather than companion-animal medicine, but the broader veterinary takeaway is familiar: once resistance becomes established, it tends to diversify and spread faster than treatment programs adapt. For mixed and large-animal practices supporting sheep clients, especially in regions with heavy anthelmintic use, studies like this help explain why a deworming protocol that once worked can start failing unevenly across farms or even across groups within the same flock. (cambridge.org)

What to watch: The next step is whether field studies tie these SNP patterns more directly to treatment outcomes in Xinjiang flocks, and whether surveillance programs expand to track E198A, F200Y, and other emerging variants side by side over time. (sciencedirect.com)